Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

657
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
657
Disorders of Hemostasis01:24

Disorders of Hemostasis

768
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
768
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

6.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
6.7K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

2.6K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.6K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

5.1K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.1K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

13.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RAB5C Increases Endothelial Release of VWF by Regulating Vesicle Trafficking.

Arteriosclerosis, thrombosis, and vascular biology·2026
Same author

Historical review: more than two decades understanding the genetic architecture of hemostasis and thrombosis.

Journal of thrombosis and haemostasis : JTH·2025
Same author

Functional Genomics Link REST to Endothelial Plasticity and Atherosclerosis.

Circulation research·2025
Same author

Genetic determinants and genomic consequences of non-leukemogenic somatic point mutations.

Nature communications·2025
Same author

The Genetic Determinants and Genomic Consequences of Non-Leukemogenic Somatic Point Mutations.

medRxiv : the preprint server for health sciences·2024
Same author

Genome-wide investigation of exogenous female hormones, genetic variation, and venous thromboembolism risk.

Journal of thrombosis and haemostasis : JTH·2024
Same journal

THE GORDON WILSON MEMORIAL LECTURE.

Transactions of the American Clinical and Climatological Association·2025
Same journal

HEALTHY AGING: THE PROMISE, AND PERILS, OF GEROSCIENCE.

Transactions of the American Clinical and Climatological Association·2025
Same journal

TESTOSTERONE AND INSULIN RESISTANCE IN MEN: EVIDENCE FOR A COMPLEX BI-DIRECTIONAL RELATIONSHIP.

Transactions of the American Clinical and Climatological Association·2025
Same journal

REVISITING GLUCAGON ACTION IN DIABETES: IS IT ALL BAD?

Transactions of the American Clinical and Climatological Association·2025
Same journal

DECEASED MEMBERS 1884 THROUGH 2024.

Transactions of the American Clinical and Climatological Association·2025
Same journal

OFFICERS AND COUNCIL FALL 2025.

Transactions of the American Clinical and Climatological Association·2025
See all related articles

Related Experiment Video

Updated: Jun 17, 2025

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

21.6K

GENETIC DETERMINANTS OF THROMBOSIS.

Charles J Lowenstein1

  • 1BALTIMORE, MARYLAND.

Transactions of the American Clinical and Climatological Association
|August 13, 2024
PubMed
Summary
This summary is machine-generated.

Genetic variants contribute to venous thromboembolism (VTE), a significant health issue. Genome-wide association studies (GWAS) are identifying new genetic factors and pathways for VTE, potentially leading to novel therapies.

More Related Videos

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

18.9K
In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

8.9K

Related Experiment Videos

Last Updated: Jun 17, 2025

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

21.6K
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

18.9K
In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

8.9K

Area of Science:

  • Genetics
  • Thrombosis
  • Molecular Biology

Background:

  • Venous thromboembolism (VTE) represents a substantial cause of illness and death in the US.
  • While both genetic and acquired factors contribute to VTE, the specific genetic variants influencing risk remain incompletely understood.
  • Recent advancements in genetic research have begun to elucidate the underlying mechanisms of VTE.

Purpose of the Study:

  • To explore the genetic underpinnings of venous thromboembolism (VTE).
  • To identify novel genetic loci associated with VTE through genome-wide association studies (GWAS).
  • To investigate the functional roles of candidate genes identified by GWAS in VTE pathogenesis.

Main Methods:

  • Utilizing genome-wide association studies (GWAS) to identify genetic variants associated with VTE.
  • Performing functional characterization of candidate genes discovered through GWAS.
  • Analyzing newly uncovered pathways involved in the regulation of VTE.

Main Results:

  • Genome-wide association studies (GWAS) have successfully identified several novel genetic loci linked to VTE.
  • Initial characterization of these loci has revealed previously unknown biological pathways implicated in VTE.
  • Candidate genes emerging from GWAS present potential targets for further investigation.

Conclusions:

  • Genetic variants play a critical role in the development of venous thromboembolism (VTE).
  • GWAS are instrumental in discovering novel genetic factors and pathways relevant to VTE.
  • Functional studies of GWAS-identified genes may yield new therapeutic strategies for thrombosis and bleeding disorders.